share_log

Despite Delivering Investors Losses of 57% Over the Past 3 Years, Micro-Tech (Nanjing)Ltd (SHSE:688029) Has Been Growing Its Earnings

Despite Delivering Investors Losses of 57% Over the Past 3 Years, Micro-Tech (Nanjing)Ltd (SHSE:688029) Has Been Growing Its Earnings

尽管在过去3年中给投资者带来了57%的亏损,南微医学(南京)有限公司(SHSE:688029)的收入仍在增长。
Simply Wall St ·  09/11 18:10

The truth is that if you invest for long enough, you're going to end up with some losing stocks. But long term Micro-Tech (Nanjing) Co.,Ltd (SHSE:688029) shareholders have had a particularly rough ride in the last three year. Sadly for them, the share price is down 58% in that time.

事实上,如果你投资足够长的时间,你会最终遇到一些亏损的股票。但是长期以来,南微医学(南京)有限公司(SHSE:688029)的股东在过去三年中经历了一次特别艰难的旅程。遗憾的是,在那段时间里,股价下跌了58%。

On a more encouraging note the company has added CN¥379m to its market cap in just the last 7 days, so let's see if we can determine what's driven the three-year loss for shareholders.

更令人鼓舞的是,在过去的7天里,公司市值增加了3,7900万元人民币,所以让我们看看是什么导致股东们在过去三年中遭受了亏损。

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

引用巴菲特的话顺便说一下,“船只将环游世界,但支持地球平面学会的人将大有可为。 在市场上,价格和价值之间将继续存在巨大的差异...”通过比较EPS和股价变化,我们可以了解到投资者对公司的态度随时间的变化程度。

During the unfortunate three years of share price decline, Micro-Tech (Nanjing)Ltd actually saw its earnings per share (EPS) improve by 22% per year. Given the share price reaction, one might suspect that EPS is not a good guide to the business performance during the period (perhaps due to a one-off loss or gain). Alternatively, growth expectations may have been unreasonable in the past.

在不幸的三年股价下跌期间,南微医学(南京)有限公司的每股收益(EPS)实际上每年提高了22%。考虑到股价的反应,有人可能会怀疑EPS不是该时期业务绩效的良好指标(可能是因为一次性损益),或者过去的增长预期可能过于不合理。

Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.

由于EPS的变化似乎与股价的变化不相关,因此值得查看其他指标。

With a rather small yield of just 1.6% we doubt that the stock's share price is based on its dividend. We note that, in three years, revenue has actually grown at a 13% annual rate, so that doesn't seem to be a reason to sell shares. It's probably worth investigating Micro-Tech (Nanjing)Ltd further; while we may be missing something on this analysis, there might also be an opportunity.

该股票的股价并不是基于其股息的相对较低的1.6%的收益率。我们注意到,过去三年,营业收入实际上以13%的年增长率增长,因此这似乎不是卖出股票的原因。或许进一步调查南微医学(南京)有意义;虽然我们也许在这种分析中忽略了一些东西,但也可能有机会。

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

您可以看到以下收益和营收的变化情况(通过单击图像了解精确值)。

big
SHSE:688029 Earnings and Revenue Growth September 11th 2024
SHSE:688029盈利和营收增长2024年9月11日

We know that Micro-Tech (Nanjing)Ltd has improved its bottom line lately, but what does the future have in store? So it makes a lot of sense to check out what analysts think Micro-Tech (Nanjing)Ltd will earn in the future (free profit forecasts).

我们知道,南微医学(南京)最近改善了其底线,但未来会产生什么影响呢?因此,检查一下分析师认为南微医学(南京)未来将获得多少收益(免费利润预测)是很有道理的。

A Different Perspective

不同的观点

Micro-Tech (Nanjing)Ltd shareholders are down 18% over twelve months (even including dividends), which isn't far from the market return of -20%. Unfortunately, last year's performance is a deterioration of an already poor long term track record, given the loss of 6% per year over the last five years. Weak performance over the long term usually destroys market confidence in a stock, but bargain hunters may want to take a closer look for signs of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Even so, be aware that Micro-Tech (Nanjing)Ltd is showing 1 warning sign in our investment analysis , you should know about...

南微医学(南京)的股东在过去十二个月中下跌了18%(包括分红),这与市场回报率-20%差不多。不幸的是,去年的表现是已经不好的长期跟踪记录的恶化,因为在过去五年中每年亏损6%。长期表现疲软通常会摧毁对股票的市场信心,但淘宝猎人可能希望更仔细地观察是否出现转机的迹象。我认为长期股价作为业绩的一个代理人是非常有趣的,但要真正获得洞察力,我们还需要考虑其他信息。尽管如此,请注意,南微医学(南京)在我们的投资分析中显示了1个警告信号,你应该了解一下……

If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.

如果您像我一样,就不会希望错过这份免费的内部人士正在购买的低估小市值股票列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所上市的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发